期刊文献+

Dyrk1B在宫颈癌组织中的表达及其临床意义 被引量:3

Expression and clinical significance of Dyrk1B in cervical carcinoma
下载PDF
导出
摘要 目的探讨Dyrk1B在宫颈癌组织中的表达及其临床意义。方法利用免疫组化检测Dyrk1B在60例宫颈癌组织、60例宫颈癌癌旁组织和60例正常宫颈组织中的表达,分析Dyrk1B在宫颈癌组织中的表达状况以及与宫颈癌临床参数的关系。结果Dyrk1B在宫颈癌组织中的表达(60/60,100%)明显高于癌旁组织(26/40,65%)和正常宫颈组织(16/40,40%),三组间比较差异有统计学意义(χ2=88.21,P〈0.01)。Dyrk1B的强阳性率与宫颈癌的组织学分化程度有明显相关性(P〈0.05),与宫颈癌患者的年龄、临床分期和有无淋巴转移等无明显相关性(P〉0.05)。结论Dyrk1B在宫颈癌中高表达,提示其可能参与了肿瘤的发生和发展,并有望成为宫颈癌早期诊断的标志物和治疗的靶基因。 Objective To investigate the expression of DyrklB in cervical cancer and its clinical significance. Methods Immunohistochemical methods were used to detect the expression levels of DryklB in 60 cases cervical carcinoma tis- sues, 60 cases of cervical cancer adjacent tissues and 60 cases normal cervical tissues. DryklB expression in cervical carcinoma and relationship with clinical parameters of cervical carcinoma. Results The expression of DyrklB in cervi- cal cancer tissues was significantly higher than that in cervical cancer adjacent tissues and normal cervical tissues, and there was statistical significance between the three groups(χ2=88.21 ,P〈0.01). There was a significant correlation be- tween the strong positive rate of Dyrklb and degree of histological differentiation(P〈0.05),but there was no correlation between the strong positive rate of Dyrklb and patient's age, clinical stage and lymph node metastasis of cervical car- cinoma(P〉0.05). Conclusion The expression level of Dyrklb in cervical carcinoma tissues is high,which indicates that it may participate in the occurrence and development of cervical carcinoma , and it may become a tumor marker for clinical early diagnosis and a new target gene for. treatment of cervical carcinoma.
出处 《中国现代医生》 2015年第28期1-3,7,共4页 China Modern Doctor
基金 浙江省宁波市自然科学基金项目(2013A610229)
关键词 Mirk/Dyrk1B 宫颈癌 免疫组化 Mirk/Dyrk 1 B Cervical carcinoma Immunohistoehemical
  • 相关文献

参考文献22

  • 1Duan Z,Brakora KA,Seiden MV. Inhibition of ABCB1 (MDRI) and ABCBg (MDR3) expression by small inter- fering RNA and reversal of paclitaxel resistance in human ovarian cancer cells[J]. Mol Cancer Ther, 2004,3 (7) : 833- 838.
  • 2Becker W, Weber Y, Wetet K, et al. Sequence characteris- tics subcellular localization,and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases[J]. Biol Chem, 1998,273 (40) : 25893-25902.
  • 3Lee K,Deng X,Friedman E. Mirk protein kinase is a mi- togen-activated protein kinase substrate that mediates survival of colon cancer cells[J]. Cancer Res,2000,60(13) : 3631-3637.
  • 4Leder S,Weber Y, Altafaj X,et al. Cloning and character- ization of DyrklB,a novel member of the Dyrk family of protein kinases[J]. Biochem Biophys Res Commun, 1999, 254 (2) : 474-479.
  • 5Becker W,Joost HG. Structural and functional character- istics of Dyrk,a novel subfamily of protein kinase with dual specificity[J]. Prog Nucleic Acid Res Mol Biol, 1999, (62) : 1-17.
  • 6Lee K,Den X,Friedman E. Mirk protein kinase is a mito- gen-activated protein kinase substrate that mediates sur- vival of colon cancer cells[J]. Cancer Research,2000,60 (13) -3631-3637.
  • 7Deng X,DZE,S Li AN,et al. The kinase Mirk/DyrklB me- diates cell survival in pancreatic ductal adenocarcinoma[J]. Cancer Res,2006,66(8) :4149-4158.
  • 8Deng X, Friedman E. Mirk kinase inhibition blocks the in vivo growth of pancreatic cancer cells[J]. Genes Cancer, 2014,5(9-10) :337-347.
  • 9Lee K, Deng X, Friedman E. Mirk protein kinase is a mi- togen-activated protein kinase substrate that mediates survival of colon cancer cells[J]. Cancer Res,2000,60(13) : 3631-3617.
  • 10Deng X,Ewton DZ,Li S,et al. The kinase Mirk/Dyrktb mediates cell survival in non-small cell lung cancer cells[J]. Cancer Research, 2006,66 (8) : 4149-4158.

二级参考文献24

  • 1王炯,贾书花,肖鹏.阴道镜下宫颈活检在诊断宫颈疾病中的应用[J].长治医学院学报,2006,20(3):212-214. 被引量:4
  • 2Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden: Glohoean 2000. Int J Cancer, 2001,94:153-156.
  • 3Lee K, Den X, Friedman E. Mirk protein kinase is a mitogen - activated protein kinase substrate that mediates survival of colon cancer cells [J] .Caneer Research, 2000, 60:3631.
  • 4Deng X, Ewton DZ, L S et al. The kinase Mirk/Dyrklb mediates cell survival in non - small cell lung cancer cells [J].Cancer Research, 2006, 66:4149.
  • 5Gao J, Zheng Z, Rawal Bet al. Mirk/Dyrklb, a novel therapeutic target, mediates cell survival in non -small cell lung cancer cells [J] .Cancer Biol Ther, 2009, 8 (17) : 1671.
  • 6Mercer SE, Ewton DZ, Shah Set al. Mirk/Dyrklb mediates cell survival in rhabdomyosarcomas [J] . Cancer Research, 2006, 66:5143.
  • 7Woodward ER, Sleightholme HV, Considine AM et al. Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high - risk and population risk women is ineffective[J].BJOG, 114 (12) : 1500.
  • 8Jin K, Ewton DZ, Park Set al. Mirk regulates the exit of colon cancer cells from quiescence[J].Biological Chemistry,2009,284(34) :22916.
  • 9Hu J, Friedman E. Depleting Mirk kinase increases cisplatin toxicity in ovarian cancer ceils [J].Genes Cancer, 2010, 1 (8) : 803.
  • 10Becker W, Weber Y, Welzel K, et "I. Sequence characieristics , subcellular localization . and substrate specificity of DYRK-relaled kinases, a novel family of dual specificity protein kinases . .r Bioi Chem , 1998, 273 : 25893 -25902.

共引文献7

同被引文献16

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部